Findings from a retrospective analysis reported a 7.5% prevalence of thrombotic events among coronavirus disease 2019 (COVID-19) patients. The study was conducted at 3 university health systems in the Chicago Metropolitan Area. The investigators also evaluated and identified risk factors for thrombosis. The study, presented at the American Society of Hematology (ASH) 2020 Conference, was led by Stephanie Berg, DO, Division of Hematology and Oncology, Loyola University Medical Center, and was conducted between March 2020 – May 2020. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more